Review article: The potential role of nitric oxide in chronic inflammatory bowel disorders

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 2, 1999, Pages 135-144

  Perner, A ^a   Rask Madsen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LEUKOTRIENE B4; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; CELL ADHESION; COLON MUCOSA; CROHN DISEASE; CYTOTOXICITY; DIARRHEA; ENTERITIS; EPITHELIUM; EXTRAVASATION; HUMAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIORITY JOURNAL; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM; VENULE;

ANIMALS; CHRONIC DISEASE; ENZYME INHIBITORS; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0033064252     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00453.x     Document Type: Article

References (92)

1. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991; 325: 928-37.
2. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996; 31(Suppl.216): 149-59.
3. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
4. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424-37.
5. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996; 270: G225-37.
6. McDonald LJ, Murad F. Nitric oxide and cGMP signalling. Adv Pharmacol 1995; 34: 263-73.
7. Kanwar S, Kubes P. Nitric oxide is an anti-adhesive molecule for leukocytes. New Horiz 1995; 3: 93-104.
8. Snyder SH, Bredt DS. Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 1991; 12: 125-8.
9. Gaginella TS, Kachur JF, Tamai H, Keshavarzian A. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology 1995; 109: 2019-28.
10. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 7: 1124-34.
11. Marletta MA. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chem Res Toxicol 1988; 1: 249-57.
12. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and super-oxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
13. Magee PN. Nitrosamines and human cancer: introduction and overview. Eur J Cancer Prev 1996; 5: 7-10.
14. Bredt DS, Hwang PM, Glatt CE, Löwenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714-18.
15. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-18.
16. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996; 17: 1171-4.
17. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 1995; 58: 643-9.
18. Zhang X, Laubach VE, Alley EW, et al. Transcriptional basis for hyporesponsiveness of the human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-γ. J Leukoc Biol 1996; 59: 575-85.
19. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κ B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-8.
20. Salzman AL, Eaves-Pyles T, Linn SC, Denenberg AG, Szabó C. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998; 114: 93-102.
21. Peng HB, Libby P, Liao JK. Induction and stabilization of I κ B α by nitric oxide mediates inhibition of NF-κ B. J Biol Chem 1995; 270: 14214-19.
22. Whittle BJR. Nitric oxide - a mediator of inflammation or mucosal defence. Eur J Gastroenterol Hepatol 1997; 9: 1026-32.
23. Tepperman BL, Brown JF, Whittle BJ. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993; 265: G214-18.
24. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995; 109: 1497-502.
25. Kimura H, Miura S, Shigematsu T, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci 1997; 42: 1047-54.
26. Roberts PJ, Morgan K, Shorthouse M, Hunter JO, Middleton SJ. Inducible NOS (iNOS) is expressed in the normal human colon. Gastroenterology 1997; 112: A1073(Abstract).
27. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998; 427: 225-8.
28. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 1989; 2: 1057-62.
29. Tannenbaum SR, Weissman M, Fett B. The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol 1976; 14: 549-52.
30. Duncan C, Dougall H, Johnston P, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995; 1: 546-51.
31. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric oxide production in humans: Measurements in expelled air. Gut 1994; 55: 1543-6.
32. McKnight GM, Smith LM, Drummond RS, Duncan CW, Golden M, Benjamin N. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut 1997; 40: 211-14.
33. Benjamin N, O'Driscoll F, Dougall H, et al. Stomach NO Synthesis. Nature 1994; 368: 502(Letter.
34. Nagase S, Takemura K, Ueda A, et al. A novel non-enzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun 1997; 233: 150-3.
35. Hata Y, Kawabe T, Hiraishi H, Ota S, Terano A, Ivey KJ. Hydrogen peroxide-mediated cytotoxicity to cultured colonic epithelial cells. Life Sci 1997; 60: 2221-30.
36. Goretski J, Zafiriou OC, Hollocher TC. Steady-state nitric oxide concentrations during denitrification. J Biol Chem 1990; 265: 11535-8.
37. Brittain T, Blackmore R, Greenwood C, Thomson AJ. Bacterial nitrite-reducing enzymes. Eur J Biochem 1992; 209: 793-802.
38. Hultén L, Lindhagen J, Lundgren O, Fasth S, Åhrén C. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology 1977; 72: 388-96.
39. Bacaner MB. Quantitative measurement of regional colon blood flow in the normal and pathological human bowel. Gastroenterology 1966; 51: 764-77.
40. Hata F, Ishii T, Kanada A, et al. Essential role of nitric oxide in descending inhibition in the rat proximal colon. Biochem Biophys Res Commun 1990; 172: 1400-6.
41. Salzman AL, Denenberg AG, Ueta I, O'Connor M, Linn SC, Szabó C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996; 270: G565-73.
42. Kennedy M, Denenberg AG, Szabó C, Salzman AL. Poly (ADP-ribose) synthase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998; 114: 510-18.
43. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996; 93: 6770-4.
44. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 1997; 94: 6954-8.
45. Seo HG, Takata I, Nakamura M, et al. Induction of nitric oxide synthase and concomitant suppression of superoxide dismutases in experimental colitis in rats. Arch Biochem Biophys 1995; 324: 41-7.
46. Roediger WE, Lawson MJ, Nance SH, Radcliffe BC. Detectable colonic nitrite levels in inflammatory bowel disease-mucosal or bacterial malfunction? Digestion 1986; 35: 199-204.
47. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341: 465-6.
48. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F. Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-23.
49. Lundberg JON, Hellström PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344: 1673-4.
50. Herulf M, Ljung T, Hellström PM, Weitzberg E, Lundberg JON. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998; 33: 164-9.
51. Reynolds PD, Middleton SJ, Hansford GM, Hunter JO. Confirmation of nitric oxide synthesis in active ulcerative colitis by infra-red diode laser spectroscopy. Eur J Gastroenterol Hepatol 1997; 9: 463-6.
52. Perner A, Hillingso J, Nordgaard I, Matzen P, Højgaard L, Rask-Madsen J. Nitric oxide in colonic inflammation: Proinflammatory mediator or protective factor? Gut 1997; 41(Suppl. 3): A17(Abstract).
53. Singer H, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-85.
54. Kimura H, Hokari R, Miura S, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42: 180-7.
55. Iwashita E, Miyahara T, Hino K, Tokunaga T, Wakisaka H, Sawazaki Y. High nitric oxide synthase activity in endothelial cells in ulcerative colitis. J Gastroenterol 1995; 30: 551-4.
56. Kubes P, Reinhardt PH, Payne D, Woodman RC. Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine. Am J Physiol 1995; 269: G34-41.
57. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 1996; 93: 318-26.
58. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7: 1293-9.
59. McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112: 1022-7.
60. Boughton Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-40.
61. Lundberg JON, Hellström PM, Lundberg JM, Alving K. Nitric oxide in ulcerative colitis. Lancet 1995; 345: 449(Letter).
62. Lindström CG. 'Collagenous colitis' with watery diarrhoea - a new entity? Pathol Eur 1976; 11: 87-9.
63. Katsinelos P, Katsos I, Patsiaoura K, Xiarchos P, Goulis I, Eugenidis N. A new endoscopic appearance of collagenous colitis. Endoscopy 1997; 29: 135.
64. Bohr J, Tysk C, Eriksson S, Abrahamsson H, Järnerot G. Collagenous colitis: A retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-51.
65. Rask-Madsen J, Grove O, Hansen MG, Bukhave K, Nielsen HR. Colonic transport of water and electrolytes in a patient with secretory diarrhea due to collagenous colitis. Dig Dis Sci 1983; 28: 1141-6.
66. Hillingsø J, Nordgaard I, Munkholm P, et al. Greatly increased mucosal nitric oxide production in patients with collagenous colitis. Gastroenterology 1997; 112: A995(Abstract).
67. Lundberg JON, Herulf M, Olesen M, et al. Increased nitric oxide production in collagenous colitis and lymphocytic colitis. Eur J Clin Invest 1997; 27: 869-71.
68. Stack W, Filipowicz B, Hawkey C. Nitric oxide donating compounds stimulate human colonic ion transport in vitro. Gut 1996; 39: 93-9.
69. Sloth H, Bisgaard C, Grove A. Collagenous colitis: a prospective trial of prednisolone in six patients. J Intern Med 1991; 229: 443-6.
70. Järnerot G, Tysk C, Bohr J, Eriksson S. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109: 449-55.
71. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-7.
72. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun 1990; 172: 1042-8.
73. Sandoval M, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997; 113: 1480-8.
74. Reynolds PD, Middleton SJ, Shorthouse M, Hunter JO. The effects of aminosalicylic acid derivatives on nitric oxide in a cell-free system. Aliment Pharmacol Ther 1995; 9: 491-5.
75. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-30.
76. Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994; 271: 1114-21.
77. Dobosz M, Mionskowska L, Dobrowolski S, et al. Is nitric oxide and heparin treatment justified in inflammatory bowel disease? An experimental study. Scand J Clin Lab Invest 1996; 56: 657-63.
78. Pfeiffer CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol 1995; 47: 827-32.
79. Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995; 268: G673-84.
80. Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995; 37: 247-55.
81. Rachmilewitz D, Karmeli F, Okon E. Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. Gastroenterology 1995; 109: 98-106.
82. Ribbons KA, Currie MG, Connor JR, et al. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey. J Pharmacol Exp Ther 1997; 280: 1008-15.
83. Conner EM, Chen Y, Grisham MB. Effect of nitric oxide synthse inhibition on dextran sulfate sodium-induced colitis in rats and mice. Gastroenterology 1995; 108: A801(Abstract).
84. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153: 1251-6.
85. Pepke-Zaba J, Higenbottam TW, Dinh XA, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-4.
86. Klatt P, Heinzel B, Mayer B, et al. Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor. FEBS Lett 1992; 305: 160-2.
87. Southan GJ, Szabó C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996; 51: 383-94.
88. Garvey EP, Oplinger JA, Tanoury GJ, et al. Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothiourcas. J Biol Chem 1994; 269: 26669-76.
89. Griffiths MJ, Messent M, MacAllister RJ, Evans TW. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110: 963-8.
90. Dougall HT, Smith L, Duncan C, Benjamin N. The effect of amoxycillin on salivary nitrite concentrations: an important mechanism of adverse reactions? Br J Clin Pharmacol 1995; 39: 460-2.
91. Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: A clinical trial. Crit Care Med 1995; 23: 259-64.
92. Laszlo F, Evans SM, Whittle BJ. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 1995; 272: 169-75.